Make better investment decisions with Simply Wall St’s easy, visual tools that give you a competitive edge.
The White House mandate to speed up nuclear power systems for space has pushed NuScale Power (SMR) into the spotlight, as investors reassess its NRC approved small modular reactor design and large US deployment plans.
See our latest analysis for NuScale Power.
The White House space nuclear mandate has coincided with a sharp move in NuScale, with a 37.35% 7 day share price return and a 10.87% 1 day share price return contrasting with a 22.44% decline year to date and a 13.42% 1 year total shareholder return. This suggests short term momentum building on top of a mixed recent record.
If this surge in interest around space and nuclear has your attention, it may be a good moment to broaden your search with our 93 nuclear energy infrastructure stocks
With NuScale still loss making on US$31.479 million of revenue and trading at US$12.65, recent gains and a value score of 1 raise a simple question: is there mispricing here, or are investors already banking on future growth?
The narrative fair value of $0.81 sits far below NuScale Power’s last close at $12.65, which immediately raises questions about how expectations line up with the current share price.
As of today, they are transitioning from an engineering and development phase to commercial deployment. Massive Cash Buffer: NuScale ended 2025 with $1.3 billion in liquidity. This was achieved through an aggressive $750 million share sale (ATM program) in late 2025. This gives them roughly 2 to 3 years of runway at current spending levels.
Want to see what kind of revenue ramp and margin shift would need to justify such a gap to fair value? The narrative leans hard on aggressive top line growth assumptions, delayed profitability and a premium future earnings multiple that usually belongs to much more established businesses.
Result: Fair Value of $0.81 (OVERVALUED)
Have a read of the narrative in full and understand what’s behind the forecasts.
However, this story can break if legal outcomes around ENTRA1 or further equity raises (after the recent US$750 million program) hit confidence or dilute shareholders again.
Find out about the key risks to this NuScale Power narrative.
If this mix of concern and optimism around NuScale feels hard to balance, do not wait on others to frame it for you. Instead, weigh the 1 key reward and 3 important warning signs
If NuScale has sharpened your focus, do not stop with one stock. Broaden your watchlist now so you are not chasing the next move after it happens.